IDH1 and oligodendroglioma: According to previous reports, patients with oligodendrogliomas tended to have longer PFS than patients with IDH-mutant astrocytic tumors in our cohort, and IDH wild-type astrocytic tumors had the most unfavorable prognosis [24, 25].